Grant: Collaborative Health Research Projects
University of Toronto
$77,858.00
Characterization and mitigation of experimental and natural viral bioaerosols
EF 2015-16
Résumé
We have gained extraordinarily detailed knowledge in the past decade about the molecular nature of respiratory viruses, yet
we know relatively little about how they spread. Resolution of this issue is essential for developing evidence-based strategies
to prevent transmission of these viruses. The emergence of novel respiratory viruses such as the H7N9 avian influenza virus
and the Middle East Respiratory Syndrome coronavirus (MERS-CoV) highlights the importance of identifying means by
which to control infectious bioaerosols in order to reduce risk to the Canadian public. A decade ago SARS-CoV caused
death and significant disruption; panic and alarm stemmed from the lack of knowledge of the mode(s) of transmission of this
novel virus. Unfortunately, this question remains unresolved today.
We have identified important knowledge gaps and we propose to develop sampling tools and evaluate methods to mitigate
the dispersion of natural and experimental aerosols. We have partnered with two Canadian companies and the Public Health
Agency of Canada to ensure efficient knowledge transfer about respiratory virus transmission into the applications sector.
We will utilize our established in vitro and in vivo (ferret) transmission models for influenza virus, as well
as state-of-the-art aerosol characterization systems to evaluate a new viral aerosol detection instrument developed with
Airmax. We will also use these systems to evaluate a novel application of a traditional germicidal approach that utilizes
pulsed ultraviolet developed by Topnotch. These findings will have a significant impact on how we apply infection prevention
and control measures for seasonal and emerging/re-emerging respiratory viruses, whilst informing public health policy for the
control of these agents.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
478452-2015
Name nom
Mubareka, Samira
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
77858
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Characterization and mitigation of experimental and natural viral bioaerosols
Keyword
NSERC
Application summary
We have gained extraordinarily detailed knowledge in the past decade about the molecular nature of respiratory viruses, yet
we know relatively little about how they spread. Resolution of this issue is essential for developing evidence-based strategies
to prevent transmission of these viruses. The emergence of novel respiratory viruses such as the H7N9 avian influenza virus
and the Middle East Respiratory Syndrome coronavirus (MERS-CoV) highlights the importance of identifying means by
which to control infectious bioaerosols in order to reduce risk to the Canadian public. A decade ago SARS-CoV caused
death and significant disruption; panic and alarm stemmed from the lack of knowledge of the mode(s) of transmission of this
novel virus. Unfortunately, this question remains unresolved today.
We have identified important knowledge gaps and we propose to develop sampling tools and evaluate methods to mitigate
the dispersion of natural and experimental aerosols. We have partnered with two Canadian companies and the Public Health
Agency of Canada to ensure efficient knowledge transfer about respiratory virus transmission into the applications sector.
We will utilize our established in vitro and in vivo (ferret) transmission models for influenza virus, as well
as state-of-the-art aerosol characterization systems to evaluate a new viral aerosol detection instrument developed with
Airmax. We will also use these systems to evaluate a novel application of a traditional germicidal approach that utilizes
pulsed ultraviolet developed by Topnotch. These findings will have a significant impact on how we apply infection prevention
and control measures for seasonal and emerging/re-emerging respiratory viruses, whilst informing public health policy for the
control of these agents.